Episode 56: SPONSORED Advances in Stool Testing: The GI-MAP GI-Microbial Assay Plus

DSL’s GI-MAP stool test is, as CEO Tony Hoffman states, “a
clinician diagnostic tool;” it’s not a microbiome test. Yes, of
course the GI-MAP looks at the microbiome, but it's not a broad
sweep of the myriad of bugs taking up residence. Rather, it’s a
carefully curated investigation of organisms with demonstrated
imbalance potential, be it pathogenic or dysbiotic in nature. The
test is designed to be user-friendly, interpreted rapidly,
logically, providing clearly actionable data that, when addressed,
gets results. I’ve known Tony for years; we were both involved in
the development of the first stool test using PCR analysis offered
to clinicians. He’s brilliant, fun to listen to, and offers loads
of pearls in this conversation. Take a listen, share, comment, and
let us know what you think!